The real-world effectiveness and safety of fingolimod in relapsing-remitting multiple sclerosis patients: An observational study

Open Access

Peer-reviewed

Research Article

Guillermo Izquierdo ,

* E-mail: gia@us.es

Affiliation Servicio de Neurología, Hospital Universitario Virgen Macarena, Sevilla, Andalucia, Spain

http://orcid.org/0000-0002-6340-5609

⨯
Fátima Damas,

Affiliation Servicio de Neurología, Hospital Universitario Virgen Macarena, Sevilla, Andalucia, Spain
⨯
Maria Dolores Páramo,

Affiliation Servicio de Neurología, Hospital Universitario Virgen Macarena, Sevilla, Andalucia, Spain
⨯
Juan Luis Ruiz-Peña,

Affiliation Servicio de Neurología, Hospital Universitario Virgen Macarena, Sevilla, Andalucia, Spain
⨯
Guillermo Navarro

Affiliation Servicio de Neurología, Hospital Universitario Virgen Macarena, Sevilla, Andalucia, Spain
⨯

Reader Comments (0)

Lesions
Is the Subject Area "Lesions" applicable to this article?

Thanks for your feedback.
Immunomodulation
Is the Subject Area "Immunomodulation" applicable to this article?

Thanks for your feedback.
Multiple sclerosis
Is the Subject Area "Multiple sclerosis" applicable to this article?

Thanks for your feedback.
Observational studies
Is the Subject Area "Observational studies" applicable to this article?

Thanks for your feedback.
Magnetic resonance imaging
Is the Subject Area "Magnetic resonance imaging" applicable to this article?

Thanks for your feedback.
Clinical trials
Is the Subject Area "Clinical trials" applicable to this article?

Thanks for your feedback.
Safety studies
Is the Subject Area "Safety studies" applicable to this article?

Thanks for your feedback.
Spain
Is the Subject Area "Spain" applicable to this article?

Thanks for your feedback.